TLX Telix Pharmaceuticals Limited Stock — fundamentals, financials & AI research · AlgoThesis

Stocks›Healthcare›TLX

TLX

Name: AlgoThesis
Author: algothesis

Telix Pharmaceuticals Limited

NasdaqResearch view

Healthcare · Pharmaceutical Preparations · SEC EDGAR FY 2024-12-31

Price history

Interactive · live data via TradingView

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2024-12-31

SectorHealthcare

IncomeAUD 49.9M

SalesAUD 783.2M

Book/shAUD 1.68

Cash/shAUD 2.10

Dividend TTM—

Payout—

Employees—

IPO—

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

AUD 160.1M

2022

AUD 502.5M

2023

AUD 783.2M

2024

Financials — annual

SEC EDGAR · last 3 FY · tap a row to explain it

AUD	FY2022	FY2023	FY2024
Revenue	AUD 160.1M	AUD 502.5M	AUD 783.2M
Gross Profit	AUD 94.9M	AUD 314.4M	AUD 509.7M
Operating Income	AUD -91.9M	AUD 15.8M	AUD 82.1M
Net Income	AUD -104.1M	AUD 5.2M	AUD 49.9M
Diluted EPS	AUD -33.50	AUD 1.61	AUD 14.46
Operating Cash Flow	AUD -64.0M	AUD 23.9M	AUD 43.0M
Free Cash Flow	AUD -71.0M	AUD 14.2M	AUD 28.7M

Deep dive

Computed from the SEC EDGAR multi-year statements

Operating leverage — margins

GrossOperatingNet

Follow the news. Follow the move.

TLX story timeline

Company updates and connected market context, with the dated price move attached.

Stories

Direct

Sector context/Market context

Jul 2

Telix gets FDA alignment on prostate cancer trial expansion to US

Telix Pharmaceuticals has received FDA alignment to expand its prostate cancer radiopharmaceutical trial into the United States, a key regulatory milestone for its pipeline beyond the already-approved Illuccix. This opens a potential multi-billion dollar US market entry for its next-generation prostate cancer therapy, a catalyst that could significantly re-rate the stock if trial execution holds.

COMMUNITY · $TLX0 theses

POST YOUR TAKE →

Related Stocks

Loading peers…

Build basket with TLX Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.

TLX